ArticleAesthetic plastic surgery2025
TARD Treatment Strategy for Buffalo Hump Based on Dorsocervical Esthetic Subunits.
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical Classification of Buffalo Hump Based on Appearance and MRI: A Retrospective Study of 383 Cases.Aesthetic plastic surgery · 2026Article
- A Zone-Specific, Minimally Invasive Approach with a Rotary Cutting System for Moderate-to-Severe Fibrotic Buffalo Hump.Aesthetic plastic surgery · 2026Article
- Ultrasound-Assisted Liposuction for Idiopathic Buffalo Hump: Anatomical Considerations and Technical Implications.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The buffalo hump, characterized by abnormal fat and fibrous tissue accumulation in the dorsocervical region, presents both esthetic contours and functional challenges. Based on esthetic subunits, we proposed TARD (tumescent anesthesia, sharp cannula release and multi-port liposuction cannula aspiration for debulking) as a minimally invasive technique designed to reshape the dorsocervical contour. Forty-five patients with buffalo hump underwent the TARD from March 2022 to May 2024. Outcomes were assessed independently using a 4-point scale at 8-month follow-up. Treatment achieved favorable outcomes in 91.1% of cases (good: 44.4%; excellent: 46.7%), with mean scores of 2.4 ± 0.7. Transient numbness (26.7%) resolved within 6 months. No infection, hematoma or revision was recorded. TARD is particularly effective for fibrosis-rich dorsocervical humps, offering the advantages including minimal scars and rapid recovery. These findings establish TARD as an innovative and effective treatment method for mild to moderate fibrofatty dorsocervical hump.Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
40542239What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.